|1.||Lerner, Adam: 4 articles (08/2007 - 02/2002)|
|2.||Zollo, Massimo: 2 articles (07/2014 - 02/2004)|
|3.||Kettelhut, Isis C: 2 articles (12/2009 - 06/2007)|
|4.||Zanon, Neusa M: 2 articles (12/2009 - 06/2007)|
|5.||Podobnik, Marjetka: 2 articles (11/2009 - 12/2005)|
|6.||Visweswariah, Sandhya S: 2 articles (11/2009 - 12/2005)|
|7.||Weintraub, Lewis: 2 articles (02/2005 - 02/2002)|
|8.||Tiwari, Sanjay: 2 articles (02/2005 - 04/2004)|
|9.||Geny, Bernard: 1 article (08/2015)|
|10.||Talha, Samy: 1 article (08/2015)|
|1.||Asthma (Bronchial Asthma)
07/01/1979 - "Activity of cAMP phosphodiesterase was similar in leukocytes of healthy persons and of the patients with bronchial asthma in the period of remission. "
07/01/1979 - "[cAMP phosphodiesterase activity in the leukocytes in bronchial asthma]."
02/01/1993 - "The results indicate that (R)-rolipram inhibits the response to two distinct classes of mediator in this model of eosinophil infiltration, adding support to the contention that isozyme IV-selective cAMP phosphodiesterase inhibitors offer therapeutic potential for human asthma."
09/01/1989 - "[Characteristics of the action of euphylline and the activity of forms of cAMP phosphodiesterase in lymphocytes of patients with bronchial asthma]."
01/01/1984 - "The content of cAMP, cGMP and cAMP phosphodiesterase activity were studied in lymphocytes of bronchial asthma patients and normal persons before and 15 min after euphylline administration in a dose of 4 mg/kg. The cAMP/cGMP ratio was significantly lowered in patients. "
03/01/1989 - "Direct correlation between the efficacy of persisting giardia infection chemotherapy and the cAMP phosphodiesterase activity in blood lymphocytes was found previously. "
01/01/2011 - "A differentially expressed soluble cytosolic cAMP phosphodiesterase (LdPDEA) might be related to infection establishment by shifting trypanothione pool utilization bias toward antioxidant defense. "
07/01/1985 - "Papaverine, an inhibitor of cAMP phosphodiesterase, reduced yields of infectious vesicular stomatitis virus in HEp-2 cells approximately 100-fold if added to cultures at a concentration of 30 microM before and after virus infection. "
10/01/1978 - "To provide information on the role of nucleases in oncogenic virus infection, the activities of 3'-nucleotide phosphodiesterase (3'-NPDase), 5'-nucleotide phosphodiesterase (5'-NPDase), acid deoxyribonuclease (DNase II), and 3',5'-cyclic AMP phosphodiesterase (cAMPDase) in spleen extracts of murine sarcoma virus-infected C57BL/6 inbred mice were studied. "
11/01/1996 - "Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure."
12/01/1993 - "Despite the justifiable concern about the use of oral cyclic adenosine monophosphate phosphodiesterase (cAMP PDE) inhibitors, the intravenous preparations are clearly effective in the treatment of acute heart failure, whether it occurs de novo or complicating chronic congestive heart failure (CHF), and in low output states following cardiac surgery. "
09/01/1992 - "Positive inotropic drugs acting on beta-adrenoceptors and inhibitors of cAMP phosphodiesterase have been extensively studied for the treatment of patients with heart failure. "
05/01/1993 - "Cardiotonic drugs acting on beta-adrenoceptors and inhibitors of cAMP phosphodiesterase have been extensively studied and used for the treatment of heart failure. "
07/01/1983 - "The efficacy of the selective adenosine cyclic 3',5'-monophosphate (cAMP) phosphodiesterase (PDE) inhibitor (+/-)-rolipram and its optical isomers (0.006 to 25 mg kg-1) in inducing characteristic behavioural changes like hypothermia, hypoactivity, forepaw shaking, grooming and head twitches in rats has been examined. "
|5.||Atopic Dermatitis (Atopic Eczema)
09/01/1986 - "Monocyte localization of elevated cAMP phosphodiesterase activity in atopic dermatitis."
01/01/1985 - "Adults with atopic dermatitis or allergic respiratory disease have elevated mononuclear leukocyte cAMP-phosphodiesterase activity. "
12/01/1982 - "We measured cAMP-phosphodiesterase activity in mononuclear leukocytes of patients with atopic dermatitis and allergic rhinitis and noted consistent, significantly elevated levels. "
05/01/1993 - "Previous studies have shown that leukocytes from patients with atopic dermatitis have increased levels of cyclic adenosine monophosphate (cAMP)-phosphodiesterase activity. "
05/01/1998 - "We determined the cyclic adenosine monophosphate phosphodiesterase (cAMP-PDE) activity in peripheral blood mononuclear leucocytes from 100 patients with atopic dermatitis (AD) aged 13-57 years (mean +/- SD, 29.8 +/- 17.7 years). "
|2.||Adenosine Monophosphate (AMP)
|3.||Cyclic AMP (AMP, Cyclic)
|5.||Adenylate Cyclase (Adenylyl Cyclase)
|9.||Caffeine (No Doz)
|10.||Aquaporins (Water Channels)
|1.||Drug Therapy (Chemotherapy)
|3.||Transplantation (Transplant Recipients)
|5.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)